We comply with the
HONcode standard for trustworthy health information:
verify here

The European LeukemiaNet is an EU-funded organisation of physicians, scientists and patients with interest in leukemia. It aims to improve the treatment and knowledge about Leukemia in Europe and spread excellence. The website delivers information for physicians, patients (e.g. patient organisations in Europe), ongoing clinical trials and further information about the disease. You can get information about the European LeukemiaNet in various european languages. The European LeukemiaNet is funded by the 6th Framework Program of the European Community.

News

ELN recommendations

CML management recommendations (Baccarani et al., J Clin Oncol 2009;27:6041-51) among the 50 top cited papers of JCO 2009.

Japanese ELN recommendations for CML

The ELN recommendations for CML are now available in Japanese language. The booklet can be ordered directly from ELIC.

ELN Frontiers Meeting 2011: Abstracts available online

ELN Frontiers is an annual educational program of the EUTOS (European Treatment and Outcome Study for CML) project, a collaboration between the European LeukemiaNet and Novartis Oncology Europe. Abstracts of the meeting in Berlin are available online now.

First results of impact assessment of CT-Directive

The CT-directive 2001/20/EC (directive on clinical trials) could be adopted around 10/2011. The process is leaded by DG Sanco at the EC and described in the Roadmap (“action plan”). One element of the action plan has been the process of the public consultation of the paper "Assessment of the functioning of the 'Clinical Trials Directive' 2001/20/EC". The ELN has been one of about 100 contributors to this paper.

ELN Foundation

The ELN Foundation is a non-profit charitable organisation, which supports the goals of the European LeukemiaNet to foster science and research and to improve and enhance medical care in acute and chronic leukaemia and related disease entities.

EUTOS – eCRF – Paper version

The EUTOS for CML Registry will collect baseline, treatment and outcome data on patients with CML in Europe by implementing and enlarging the current European CML Registry. The Online access to the EUTOS – eCRF – System and the CRF paper version are available at the EUTOS website.

Events
Tu 2012/01/31 - We 2012/02/01 9th Annual Symposium of the European LeukemiaNet / 13th Annual Symposium of the German Competence Network "Acute and chronic Leukemias"
We 2012/02/22 - Sa 2012/02/25 30. German Cancer Congress Qualität sichern — Forschung fo(e)rdern
Th 2012/03/15 - Sa 2012/03/17 Perspectives in Cell and Gene based Medicines A joint conference of the 18th Annual Meeting of the German Society for Gene Therapy (DG-GT) Perspective Conferenc···
Sa 2012/04/14 - Tu 2012/04/17 118. DGIM Congress Desease, Genes, and Environment
Fr 2012/05/04 - Sa 2012/05/05 2012 European Focus on Myeloproliferative Neoplasms & Myelodysplastic Syndromes

The European Leukemia Net

182 Participating Centers in 34 Countries (1000 Researchers and Associates) are cooperating in the European Leukemia Net. The objective is to integrate the 108 leading leukemia trial groups (CML, AML, ALL, CLL, MDS, CMPD), their 105 interdisciplinary partners (diagnostics, treatment research, registry, guidelines), industry and SMEs across Europe to form a cooperative network for advancements in leukemia related research and health care (data updated February 2011).

Keywords: leukemia, leukaemia, leukämie, leucemie, leucémie, leucemia, leukemi, leukemie, lösemi, Лейкоз, λευχαιμία, سرطان الدّم, 白血病, leukemija, leukemije, leŭkemio, biaŁacka,ש"עסרטן הדם, לויקמיה